Selective changes in DNA binding activity of transcription factors in UM-X7.1 cardiomyopathic hamsters

Life Sciences

Volumn 71, Issue 20, 2002, Pages 2369-2381

  Ambra, R ^a   Di Nardo, P ^b   Fantini, C ^b   Minieri, M ^b   Canali, R ^a   Natella, F ^a   Virgili, F ^a  

^a ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Calcineurin A; DNA binding protein; Hereditary cardiomyopathic hamster; NF AT3, CREB; Oxidative stress

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR CREB; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT3; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DOWN REGULATION; HAMSTER; HEART VENTRICLE; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOGENESIS; PROTEIN DNA BINDING; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ALPHA-TOCOPHEROL; ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CALCINEURIN; CALCIUM; CARDIOMYOPATHIES; CRICETINAE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA; DNA PRIMERS; DNA-BINDING PROTEINS; GLUTATHIONE PEROXIDASE; HOMEOSTASIS; MESOCRICETUS; MICE; MICE, TRANSGENIC; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

ANIMALIA; CRICETINAE; MUS MUSCULUS;

EID: 0037019871     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02020-9     Document Type: Article

References (44)

1. Hunter J.J., Chien K.R. Signaling pathways for cardiac hypertrophy and failure. New England Journal of Medicine. 341:1999;1276-1283.
2. Bajusz E. Hereditary cardiomyopathy: a new disease model. American Heart Journal. 77:1969;686-696.
3. Straub V., Duclos F., Venzke D.P., Lee J.C., Cutshall S., Leveille C.J., Campbell K.P. Molecular pathogenesis of muscle degeneration in the delta-sarcoglycan-deficient hamster. American Journal of Pathology. 153:1998;1623-1630.
4. Jasmin G., Eu H.Y. Cardiomyopathy of hamster dystrophy. Annals of the New York Academy of Sciences. 317:1979;46-58.
5. Forman R., Parmley W.W., Sonnenblick E.H. Myocardial contractility in relation to hypertrophy and failure in myopathic Syrian hamsters. Journal of Molecular and Cellular Cardiology. 4:1972;203-211.
6. Jasmin G., Proschek L. Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. I. Progression of heart and skeletal muscle lesions in the UM-X7.1 line. Muscle and Nerve. 5:1982;20-25.
7. Di Nardo P., Fiaccavento R., Natali A., Minieri M., Sampaolesi M., Fusco A., Janmot C., Cuda G., Carbone A., Rogliani P., Peruzzi G. Embryonic gene expression in nonoverloaded ventricles of hereditary hypertrophic cardiomyopathic hamsters. Laboratory Investigation. 77:1997;489-502.
8. Carbone A., Minieri M., Sampaolesi M., Fiaccavento R., De Feo A., Cesaroni P., Peruzzi G., Di Nardo P. Hamster cardiomyocytes: a model of myocardial regeneration? Annals of the New York Academy of Sciences. 752:1995;65-71.
9. Fukuchi T., Kobayashi A., Kaneko M., Ichiyama A., Yamazaki N. Possible involvement of free radicals and antioxidants in the early stages of the development of cardiomyopathy in BIO 14.6 Syrian Hamster. Japanese Heart Journal. 32:1991;655-666.
10. Kobayashi A., Yamashita T., Kaneko M., Nishiyama T., Hayashi H., Yamazaki N. Effects of verapamil on experimental cardiomyopathy in the Bio 14.6 Syrian hamster. Journal of the American College of Cardiology. 10:1987;1128-1138.
11. Li R.K., Sole M.J., Mickle D.A., Schimmer J., Goldstein D. Vitamin E and oxidative stress in the heart of the cardiomyopathic syrian hamster. Free Radical Biology and Medicine. 24:1998;252-258.
12. Keith M.E., Ball A., Jeejeebhoy K.N., Kurian R., Butany J., Dawood F., Wen W.H., Madapallimattam A., Sole M.J. Conditioned nutritional deficiencies in the cardiomyopathic hamster heart. Canadian Journal of Cardiology. 17:2001;449-458.
13. Proschek L., Jasmin G. Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. II. Development of heart necrotic changes in relation to defective mitochondrial function. Muscle and Nerve. 5:1982;26-32.
14. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., Grant S.R., Olson E.N. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 93:1998;215-228.
15. Liang Q., De Windt L.J., Witt S.A., Kimball T.R., Markham B.E., Molkentin J.D. The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. Journal of Biological Chemistry. 6:2001;19-28.
16. Fentzke R.C., Korcarz C.E., Lang R.M., Lin H., Leiden J.M. Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart. Journal of Clinical Investigation. 101:1998;2415-2426.
17. Buttriss J.L., Diplock A.T. High-performance liquid chromatography methods for vitamin E in tissues. Methods in Enzymology. 105:1984;131-138.
18. Bieri J.G., Tolliver T.J., Catignani G.L. Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography. American Journal of Clinical Nutrition. 32:1979;2143-2149.
19. Flohé L., Gunzler W.A. Assays of glutathione peroxidase. Methods in Enzymology. 105:1984;114-121.
20. Arthur J.R. The glutathione peroxidases. Cellular and Molecular Life Sciences. 57:2000;1825-1835.
21. Shaywitz A.J., Greenberg M.E. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annual Review of Biochemistry. 68:1999;821-861.
22. Muller F.U., Boknik P., Horst A., Knapp J., Linck B., Schmitz W., Vahlensieck U., Bohm M., Deng M.C., Scheld H.H. cAMP response element binding protein is expressed and phosphorylated in the human heart. Circulation. 92:1995;2041-2043.
23. Muller F.U., Boknik P., Horst A., Knapp J., Linck B., Schmitz W., Vahlensieck U., Walter A. In vivo isoproterenol treatment leads to downregulation of the mRNA encoding the cAMP response element binding protein in the rat heart. Biochemical and Biophysical Research Communications. 215:1995;1043-1049.
24. Ball A.M., Sole M.J. Oxidative stress and the pathogenesis of heart failure. Cardiology Clinics. 16:1998;665-675.
25. Lefer D.J., Granger D.N. Oxidative stress and cardiac disease. American Journal of Medicine. 109:2000;315-323.
26. Sakanashi T., Sako S., Nozuhara A., Adachi K., Okamoto T., Koga Y., Toshima H. Vitamin E deficiency has a pathological role in myocytolysis in cardiomyopathic Syrian hamster (BIO14.6). Biochemical and Biophysical Research Communications. 181:1991;145-150.
27. 2+. Archives of Biochemistry and Biophysics. 359:1998;77-81.
28. 2+ transients in neonatal and adult rat cardiomyocytes by angiotensin II and endothelin-1. American Journal of Physiology. 270:1996;H857-H868.
29. Keung E.C. Calcium current is increased in isolated adult myocytes from hypertrophied rat myocardium. Circulation Research. 64:1989;753-763.
30. Jasmin G., Proschek L. Calcium and myocardial cell injury. An appraisal in the cardiomyopathic hamster. Canadian Journal of Physiology and Pharmacology. 62:1984;891-898.
31. Jasmin G., Solymoss B. Prevention of hereditary cardiomyopathy in the hamster by verapamil and other agents. Proceedings of the Society for Experimental Biology and Medicine. 149:1975;193-198.
32. Cohn R.D., Durbeej M., Moore S.A., Coral-Vazquez R., Prouty S., Campbell K.P. Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex. Journal of Clinical Investigation. 107:2001;R1-R7.
33. Pieper J.A. Evolving role of calcium channel blockers in heart failure. Pharmacotherapy. 16:1996;43S-49S.
34. Sun Y., Oberley L.W. Redox regulation of transcriptional activators. Free Radical Biology and Medicine. 21:1996;335-348.
35. Peng M., Huang L., Xie Z.J., Huang W.H., Askari A. Oxidant-induced activations of nuclear factor-kappa B and activator protein-1 in cardiac myocytes. Cellular and Molecular Biology Research. 41:1995;189-197.
36. Frantz S., Kelly R.A., Bourcier T. Role of TLR-2 in the activation of nuclear factor κB by oxidative stress in cardiac myocytes. Journal of Biological Chemistry. 276:2001;5197-5203.
37. Tsou H., Azhar G., Lu X.G., Kovacs S., Peacocke M., Wei J.Y. Age-associated changes in basal c-fos transcription factor binding activity in rat hearts. Experimental Cell Research. 229(2):1996;432-437.
38. De Nigris F., Youssef T., Ciafre S., Franconi F., Anania V., Condorelli G., Palinski W., Napoli C. Evidence for oxidative activation of c-Myc-dependent nuclear signaling in human coronary smooth muscle cells and in early lesions of Watanabe heritable hyperlipidemic rabbits: protective effects of vitamin E. Circulation. 102:2000;2111-2117.
39. Lehtinen S.K., Rahkila P., Helenius M., Korhonen P., Salminen A. Down-regulation of transcription factors AP-1, Sp-1, and NF-kappa B precedes myocyte differentiation. Biochemical and Biophysical Research Communications. 229:1996;36-43.
40. Rao A., Luo C., Hogan P.G. Transcription factors of the NFAT family: regulation and function. Annual Review of Immunology. 15:1997;707-747.
41. Muller F.U., Neumann J., Schmitz W. Transcriptional regulation by cAMP in the heart. Molecular and Cellular Biochemistry. 212:2000;11-17.
42. Chrivia J.C., Kwok R.P., Lamb N., Hagiwara M., Montminy M.R., Goodman R.H. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature. 365:1993;855-859.
43. Hasegawa K., Meyers M.B., Kitsis R.N. Transcriptional coactivator p300 stimulates cell type-specific gene expression in cardiac myocytes. Journal of Biological Chemistry. 272:1997;20049-20054.
44. Francois F., Godinho M.J., Grimes M.L. CREB is cleaved by caspases during neural cell apoptosis. FEBS Letters. 486:2000;281-284.